SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
Open Access
- 13 October 2020
- journal article
- review article
- Published by Elsevier BV in The Lancet
- Vol. 396 (10262), 1595-1606
- https://doi.org/10.1016/s0140-6736(20)32137-1
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Persistence of Antibodies against Middle East Respiratory Syndrome CoronavirusEmerging Infectious Diseases, 2016
- Fc receptors in antibody‐dependent enhancement of viral infectionsImmunological Reviews, 2015
- Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirusVirology Journal, 2014
- Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH- and Cysteine Protease-Independent FcγR PathwayJournal of Virology, 2011
- Follicular Helper CD4 T Cells (TFH)Annual Review of Immunology, 2011
- Duration of Antibody Responses after Severe Acute Respiratory SyndromeEmerging Infectious Diseases, 2007
- Climate Change, 2007Water, Air, & Soil Pollution, 2007
- Immunoglobulin G Antibody-Mediated Enhancement of Measles Virus Infection Can Bypass the Protective Antiviral Immune ResponseJournal of Virology, 2006
- Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronavirusesProceedings of the National Academy of Sciences of the United States of America, 2005
- A 193-Amino Acid Fragment of the SARS Coronavirus S Protein Efficiently Binds Angiotensin-converting Enzyme 2Online Journal of Public Health Informatics, 2004